Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?

PLoS Pathog. 2013;9(12):e1003784. doi: 10.1371/journal.ppat.1003784. Epub 2013 Dec 19.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity / physiology
  • Anti-Inflammatory Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / immunology
  • Hepatitis B, Chronic / immunology
  • Hepatitis B, Chronic / therapy*
  • Humans
  • Immunity, Innate / physiology
  • Immunotherapy / methods*
  • Liver / immunology


  • Anti-Inflammatory Agents
  • Antiviral Agents

Grants and funding

The work was founded by a Singapore Translational Research Award (NMRC/STaR/013/2012) to A. Bertoletti. Adam J. Gehring is funded by Saint Louis University Startup Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.